Y
Y. S. Alghamdi
Publications - 4
Y. S. Alghamdi is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has co-authored 4 publications.
Papers
More filters
Journal ArticleDOI
Use of zinc nanoparticles and/or prodigiosin to mitigate heat stress in rabbits
Hammad Khalifeh H. Aldal'In,Aljohara M. Al-Otaibi,Fatima S. Alaryani,Ifat Alsharif,Y. S. Alghamdi,Mohamed E. Abd El-Hack,Sameh A. Abdelnour +6 more
TL;DR: In this paper , the effect of zinc oxide nanoparticles (ZnNPs) and/or prodigiosin (PRG) against heat stress in growing rabbits was examined.
Journal ArticleDOI
Subtractive sequence-mediated therapeutic targets from the conserved gene clusters of Campylobacter hyointestinalis and computational inhibition assessment.
Zarrin Basharat,Y. S. Alghamdi,Mutaib M Mashraqi,Mohammed A. Makkawi,Sultan Alasmari,Saleh Alshamrani +5 more
TL;DR: Sarma et al. as discussed by the authors used subtractive computational screening of the C. hyointestinalis genome for the purpose of identifying the therapeutic targets and reported no therapeutic targets have been identified and reported in this bacterium.
Journal ArticleDOI
Effect of rifampicin combination-regimens against multi-drug resistant strains in North India
Misbahuddin M Rafeeq,A. H. Habib,Ahmad A. Alzamami,Norah A. Alturki,Mutaib M Mashraqi,Y. S. Alghamdi,Saleh Alshamrani,Afaf Alharthi,Suhail Ahmad +8 more
TL;DR: It is shown that combination-regimens namely, ‘rifampicin-cefotaxime’ and ‘ rifampICin-tetracycline’ were found to be capable of maintaining rifampsicin susceptibility in the E. coli and K. pneumoniae strains, however, this susceptibility was not maintained by only rifampingicin.
Journal ArticleDOI
Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study
Hassan H. Almasoudi,Mohammed Ageeli Hakami,Abdulfattah Yahya M Alhazmi,Mohammed A. Makkawi,Sultan Alasmari,Y. S. Alghamdi,Mutaib M Mashraqi +6 more